Abstract:Abstract Retinoic acid receptor-related orphan receptor α (RORα) and p53 are transcription factors involved in nuclear gene expression and known tumor suppressors. RORα was the first identified substrate of lysine methylation-dependent degradation. However, the mechanisms of other post-translational modifications (PTMs) that occur in RORα and p53 remain largely unknown, especially in liver cancer. Arginine methylation is a common PTM in arginine residues of nonhistone and histone proteins and affects substrate protein function and fate. We found an analogous amino acid disposition containing R37 at the ROR N-terminus compared to histone H3 residue, which is arginine methylated. Here, we provide evidence that R37 methylation-dependent degradation is carried out by protein arginine methyltransferase 5 (PRMT5). In addition, we discovered that PRMT5 regulated the interaction between the E3 ubiquitin ligase ITCH and RORα through RORα arginine methylation. Arginine methylation-dependent ubiquitination-mediated RORα degradation reduced downstream target gene activation. H2O2-induced reactive oxygen species (ROS) decreased PRMT5 protein levels, consequently increasing RORα protein levels in liver cancer in vitro and in vivo. Furthermore, the enzymatic activities of PRMT5 were directly affected by ROS via the dissociation of PRMT5-Mep50 octamer in the methylosome complex. Taken together, ROS inhibited liver cancer progression by inducing apoptosis via PRMT5-mediated methylation of RORα combined with other histone and non-histone substrates and the ITCH axis. Our results potentiate PRMT5 as an elimination target in cancer therapy, and this additional regulatory level within ROS signaling may help identify new targets for therapeutic intervention in liver cancer. Citation Format: Ji Min Lee, Hyunkyung Kim, Hyuntae Im, Hee-ji Baek. ROS inhibits enzymatic activation of PRMT5 and increases the protein stability of tumor suppressors as non-histone substrates in liver cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1493.

Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation

Abstract 4061: Depleting the cellular level of glutathione and subsequently<i>S</i>-glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

Abstract 4061: Depleting the cellular level of glutathione and subsequently S -glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

Proteomics Profiling of Arginine Methylation Defines PRMT5 Substrate Specificity

The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

CARM1-mediated Methylation of Protein Arginine Methyltransferase 5 Represses Human Γ-Globin Gene Expression in Erythroleukemia Cells

Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

The Arginine Methyltransferase PRMT5 and PRMT1 Distinctly Regulate the Degradation of Anti-Apoptotic Protein CFLARL in Human Lung Cancer Cells.

Methylation of Ribosomal Protein S10 by Protein-arginine Methyltransferase 5 Regulates Ribosome Biogenesis*

PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours

Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders

Abstract 1493: ROS inhibits enzymatic activation of PRMT5 and increases the protein stability of tumor suppressors as non-histone substrates in liver cancer

Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer

Versatility of PRMT5-induced methylation in growth control and development

PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1+CD8+ Terminal Effector T Cells and Promotes Cancer Development

Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.

Redox-dependent Regulation of End-Binding Protein 1 Activity by Glutathionylation

Glutaredoxin-1 Silencing Induces Cell Senescence Via P53/p21/p16 Signaling Axis.

PRMT5 in gene regulation and hematologic malignancies

The E3 Ubiquitin Ligase Chip Mediates Ubiquitination and Proteasomal Degradation of Prmt5

Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition